维普中文期刊产品整合服务
123篇 您的检索式:作者名="Barthet"
    题名 作者 年代 出处 被引量
1Medical treatment for sphincter of oddi dysfunction:Can it replace endoscopic sphincterotomy?显示文摘AIM:To report the results of a medical management of sphincter of oddi dysfunction(SOD) after an intermediate follow-up period.METHODS:A total of 59 patients with SOD(2 men and 57 women,mean age 51 years old) were included in this prospective study.After medical treatment for one year,the patients were clinically re-evaluated after an average period of 30 mo.RESULTS:The distribution of the patients according to the Milwaukee's classification was the following:11 patients were type 1,34 were type 2 and 14 were type 3.Fourteen patients underwent an endoscopic sphincterotomy(ES) after one year of medical treatment.The median intermediate follow-up period was 29.8 ± 3 mo(3-72 mo).The initial effectiveness of the medical treatment was complete,partial and poor among 50.8%,13.5% and 35%,respectively,of the patients.At the end of the follow-up period,37 patients(62.7%) showed more than 50% improvement.The rate of improvement in patients who required ES was not significantly different compared with the patients treated conservatively(64.2% vs 62.2%,respectively).CONCLUSION:Our study confirms that conservative medical treatment could be an alternative to endoscopic sphincterotomy because,after an intermediate follow-up period,the two treatments show the same success rates.Véronique Vitton Salah Ezzedine Jean-Michel Gonzalez Mohamed Gasmi Jean-Charles Grimaud Marc Barthet 2012World Journal of Gastroenterology2012,18,14:9
2Peroxisome proliferator-activated receptor γ agonist reduces the severity of post-ERCP pancreatitis in rats显示文摘AIM: To determine the effects of prophylactic peroxi-some proliferator-activated receptor (PPARγ) agonist administration in an experimental model of post-endoscopic retrograde cholangiopancreatography (post-ERCP) acute pancreatitis.METHODS: Post-ERCP pancreatitis was induced in male Wistar rats by infusion of contrast medium into the pancreatic duct. In additional group, rosiglitazone, a PPARγ agonist, was administered 1 h before infusion of contrast medium. Plasma and pancreas samples were obtained 6 h after the infusion.RESULTS: Infusion of contrast medium into the pan-creatic duct resulted in an inflammatory process characterized by increased lipase levels in plasma, and edema and myeloperoxidase activity (MPO) in pancreas. This result correlated with the activation of nuclear factor κB (NFκB) and the inducible NO synthase (iNOS) expression in pancreatic cells. Rosiglitazone reduced the increase in lipase and the level of edema and the increase in myeloperoxidase as well as the activation of NFκB and iNOS expression.CONCLUSION: A single oral dose of rosiglitazone, given 1 h before post-ERCP pancreatitis induction is effective in reducing the severity of the subsequent inflammatory process. The protective effect of rosiglitazone was associated with NFκB inhibition and the blockage of leukocyte infiltration in pancreas.Emma Folch-Puy Susana Granell Juan L Iovanna Marc Barthet Daniel Closa 2006World Journal of Gastroenterology2006,12,40:6
3Large endoscopic mucosal resection for colorectal tumors exceeding 4 cm显示文摘AIM:To evaluate the feasibility and the outcome of endoscopic mucosal resection(EMR)for large colorectal tumors exceeding 4 cm(LCRT)undergoing piecemeal resection. METHODS:From January 2005 to April 2008,146 digestive tumors larger than 2 cm were removed with the EMR technique in our department.Of these,34 tumors were larger than 4 cm and piecemeal resection was carried out on 26 colorectal tumors.The mean age of the patients was 71 years.The mean follow-up duration was 12 mo. RESULTS:LCRTs were located in the rectum,left colon,transverse colon and right colon in 58%,15%, 4%and 23%of cases,respectively.All were sessile tumors larger than 4 cm with a mean size of 4.9 cm (4-10 cm).According to the Paris classification,34%of the tumors were typeⅠs,58%typeⅡa,4%typeⅡb and 4%typeⅡc.Pathological examination showed tubulous adenoma in 31%,tubulo-villous adenoma in 27%,villous adenoma in 42%,high-grade dysplasia in38%,in situ carcinoma in 19%of the cases and mucosal carcinoma(m2)in 8%of the cases.The two cases(7.7%)of procedural bleeding that occurred were managed endoscopically and one small perforation was treated with clips.During follow-up,recurrence of the tumor occurred in three patients(12%),three of whom received endoscopic treatment. CONCLUSION:EMR for tumors larger than 4 cm is a safe and effective procedure that could compete with endoscopic submucosal dissection,despite providing incomplete histological assessment.Philippe Ah Soune Charles Ménard Ezzedine Salah Ariadne Desjeux Jean-Charles Grimaud Marc Barthet 2010World Journal of Gastroenterology2010,16,5:4
4Diagnosis and management of iatrogenic endoscopic perforations: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement显示文摘Gregorios Paspatis Jean-Marc Dumonceau Marc Barthet S?ren Meisner Alessandro Repici Brian Saunders Antonios Vezakis Jean Gonzalez Stine Turino Zacharias Tsiamoulos Paul Fockens Cesare Hassan 2014Endoscopy2014,,:4
5Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis显示文摘B. Bournet A. Souque P. Senesse E. Assenat M. Barthet N. Lesavre A. Aubert D. O’Toole P. Hammel P. Levy P. Ruszniewski M. Bouisson J. Escourrou P. Cordelier L. Buscail 2009Endoscopy2009,,06:2
6Complications of Endoscopic Sphincterotomy: Results From a Single Tertiary Referral Center显示文摘M. Barthet N. Lesavre A. Desjeux M. Gasmi P. Berthezene S. Berdah X. Viviand J. Grimaud 2002Endoscopy2002,,12:2
7Value of endorectal ultrasonography for dignosis rectovaginal septal endometriosis intiltrating the rectum 显示文摘Delpy R Barthet M Gasmim M 2005Endoscopy2005,37,4:1
8Evaluation of a colorimetric method for measuring the content of FFA in marine and vegetable oils 显示文摘J BARTHET V 2008Food Chemistry2008,111,:1
9Value of endorectal ultrasonography for diagnosing rectovaginal septal endometriosis infiltrating the rectum显示文摘Delpy R Barthet M Gasmi M 2005Endoscopy2005,37,4:1
10显示文摘Barthet C Hickey A J Cairns D B 1999Adv Mater1999,11,:1
11显示文摘Percy M J Barthet C Lobb J C 2000Langmuir2000,16,:1
12Synthesis and characterization of vinyl polymer-silica colloidal nanocomposites langmuir显示文摘PERCY M J BARTHET C LOBB J C 200016(17):6913-69202000,16,17:1
13Synthesis of novel polymer-silica colloidal nanocomposites via free-radical polymerization of vinyl monomers显示文摘Barthet C Hickey A J Cairns D B 1999Advanced Materials1999,11,5:1
14Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial显示文摘M. Beauchant P. Ingrand J. Favriel J. Dupuychaffray P. Capony H. Moindrot M. Barthet J. Escourrou C. Plane T. Barrioz L. Lacoste I. Ingrand 2008Endoscopy2008,,08:1
15Relationships between endosonographie appearane and clinical, or manometrie features in patients with achalasia 显示文摘BARTHET M AMBRINI P AUDIBERT P 1998Eur J Gastroenterol Hepatol1998,10,:1
16Estimation of the prevalence and incidence of chronic pancreatitis and its complications显示文摘Philippe Lévy Marc Barthet Bruno Richard Mollard Michel Amouretti Anne-Marie Marion-Audibert Fran?ois Dyard 2006Gastroenterologie Clinique et Biologique2006,,6:1
17Value of endorectal ultrasonography for diagnosing rectovaginal septal endometriosis infiltrating the rectum 显示文摘Delpy R Barthet M Gasmi M 2005Endoscopy2005,37,4:1
18Cystic and ductal tumors of the pancreas: diagnosis and management显示文摘Scoazec J Y Vullierme M P Barthet M 2013J Visc Surg2013,150,2:1
19Frequency and characteris- tics of panereatitis in patients with inflammatory bowel disease 显示文摘Barthet M Lesawe N Desplats S 2006Pancreatology2006,6,:1
20Prospective comparison of endosonography, magnetic resonance imaging and surgical findings in anorectal fistula and abscess complicating Crohn's disease显示文摘Orsoni P Barthet M Portier F 1999Br J Surg1999,86,:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费